Allarity Therapeutics, Inc. Deferred Income Tax Liabilities, Net
Allarity Therapeutics, Inc. (ALLR) had Deferred Income Tax Liabilities, Net of $0 as of 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Balance Sheet › Liabilities
us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2025-03-31
- 2024-12-31: Deferred Income Tax Liabilities, Net $0.00.
- 2024-09-30: Deferred Income Tax Liabilities, Net $0.00.
- 2024-06-30: Deferred Income Tax Liabilities, Net $432.00K.
- 2024-03-31: Deferred Income Tax Liabilities, Net $432.00K.
| Period end | Deferred Income Tax Liabilities, Net | Deferred Income Tax Liabilities, Net as first filed |
|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-31 | |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $432.00K 10-Q · filed 2024-08-05 | |
| 2024-03-31 | $432.00K 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $446.00K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $343.00K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $343.00K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $343.00K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $349.00K 10-K · filed 2024-03-08 | |
| 2022-09-30 | $619.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $656.00K 10-Q · filed 2022-10-07 | |
| 2022-03-31 | $700.00K 10-Q · filed 2022-05-27 | |
| 2021-12-31 | $1.96M 10-K · filed 2023-03-13 | |
| 2021-09-30 | $2.28M 10-Q/A · filed 2022-05-17 | $128.00K 10-Q · filed 2021-11-23 |
| 2020-12-31 | $2.13M 10-Q/A · filed 2022-05-17 | $603.00K 10-Q · filed 2021-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |